Trials / Completed
CompletedNCT07422233
Evaluation of Levetiracetam's Effectiveness and Tolerability for Treating Epilepsy in Older Adults
Investigation of Efficacy and Tolerability of Levetiracetam for Epilepsy in Elderly
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 137 (actual)
- Sponsor
- Nasim Tabrizi · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
This prospective interventional study was conducted between 2023 and 2025 at the Department of Neurology of Bouali Sina Hospital. Consecutive elderly patients presenting with epilepsy were screened for eligibility. The diagnosis of epilepsy was confirmed by the treating neurologist. The patients underwent treatment with levetiracetam. Primary and secondary outcomes were investigated as was explained before.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oral levetiracetam | Treatment with levetiracetam tablets |
Timeline
- Start date
- 2023-09-13
- Primary completion
- 2025-12-31
- Completion
- 2026-01-20
- First posted
- 2026-02-19
- Last updated
- 2026-02-19
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT07422233. Inclusion in this directory is not an endorsement.